-
Weight-loss drugs like Wegovy and Zepbound often cause nausea and other side effects. Brain scientists are looking for ways to solve this problem.
-
New York City Mayor-elect Zohran Mamdani will meet with President Trump at the White House Friday putting the frequent foe of conservatives face-to-face with one of his biggest critics.
-
Less than a year from the midterm elections, state and local voting officials from both major political parties are actively preparing for the possibility of interference by the Trump administration.
-
The U.S. government has released a new crash test dummy design that advocates believe will help make cars safer for women. Women are 73% more likely to be injured in a head-on crash than men.
-
A botulism outbreak that has sickened more than two dozen babies in 15 states has been linked to ByHeart formula sold nationwide. Here's what to know about it.
-
The Democratic lawmakers said that members of the military can and must refuse illegal orders by their superiors.
-
The child advocacy nonprofit Fairplay issued an advisory on Thursday warning people against buying AI toys this holiday season. It's not the only group.
-
Scientists have long known that plastic waste is bad for marine animals. A new study quantifies how little ingested plastic it takes to be a lethal dose.
-
U.S. employers added 119,000 jobs in September, while the unemployment rate inched up to 4.4%. The report, which was delayed by the government shutdown, may hint at the pace of hiring and firing.
-
The latest emails from Jeffrey Epstein's estate show communications with a vast web of influential figures in politics, academia, business and more, even after he registered as a sex offender.
-
Even as SNAP benefits are restored, food banks and pantries around the nation continue to feel the strain with no reprieve in sight.
-
Author Rabih Alameddine won for his novel The True True Story of Raja the Gullible (and His Mother). Other winners include a book for young people about orphans on the run in Iran during World War II.